Crocs, Inc. (NASDAQ:CROX) Stock Holdings Decreased by Charles Schwab Investment Management Inc.

Charles Schwab Investment Management Inc. lowered its stake in Crocs, Inc. (NASDAQ:CROXFree Report) by 2.9% in the 3rd quarter, according to its most recent filing with the SEC. The fund owned 707,408 shares of the textile maker’s stock after selling 21,113 shares during the period. Charles Schwab Investment Management Inc.’s holdings in Crocs were worth $102,440,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors also recently modified their holdings of the company. Bayesian Capital Management LP bought a new stake in shares of Crocs during the 1st quarter valued at about $212,000. Kennedy Capital Management LLC bought a new stake in shares of Crocs during the 1st quarter valued at about $2,103,000. Janus Henderson Group PLC grew its position in shares of Crocs by 0.5% during the 1st quarter. Janus Henderson Group PLC now owns 33,381 shares of the textile maker’s stock valued at $4,798,000 after buying an additional 173 shares during the last quarter. B. Riley Wealth Advisors Inc. grew its position in shares of Crocs by 8.8% during the 1st quarter. B. Riley Wealth Advisors Inc. now owns 3,456 shares of the textile maker’s stock valued at $497,000 after buying an additional 280 shares during the last quarter. Finally, Tidal Investments LLC grew its position in shares of Crocs by 145.8% during the 1st quarter. Tidal Investments LLC now owns 18,194 shares of the textile maker’s stock valued at $2,616,000 after buying an additional 10,791 shares during the last quarter. Institutional investors own 93.44% of the company’s stock.

Insider Buying and Selling

In other Crocs news, CFO Susan L. Healy bought 1,000 shares of the company’s stock in a transaction that occurred on Wednesday, November 13th. The shares were acquired at an average cost of $99.70 per share, for a total transaction of $99,700.00. Following the acquisition, the chief financial officer now directly owns 22,652 shares of the company’s stock, valued at $2,258,404.40. This trade represents a 4.62 % increase in their ownership of the stock. The purchase was disclosed in a document filed with the SEC, which is available through this link. Also, Director John B. Replogle bought 2,240 shares of the company’s stock in a transaction that occurred on Wednesday, October 30th. The stock was acquired at an average price of $112.60 per share, for a total transaction of $252,224.00. Following the completion of the acquisition, the director now directly owns 9,304 shares in the company, valued at approximately $1,047,630.40. This represents a 31.71 % increase in their ownership of the stock. The disclosure for this purchase can be found here. Insiders own 2.72% of the company’s stock.

Crocs Trading Down 4.1 %

Shares of NASDAQ:CROX opened at $104.06 on Wednesday. The company has a 50 day moving average of $124.58 and a 200-day moving average of $135.52. The firm has a market cap of $6.06 billion, a P/E ratio of 7.55, a P/E/G ratio of 1.07 and a beta of 2.01. Crocs, Inc. has a twelve month low of $85.71 and a twelve month high of $165.32. The company has a current ratio of 1.43, a quick ratio of 0.90 and a debt-to-equity ratio of 0.82.

Crocs (NASDAQ:CROXGet Free Report) last issued its quarterly earnings results on Tuesday, October 29th. The textile maker reported $3.60 earnings per share for the quarter, topping analysts’ consensus estimates of $3.10 by $0.50. Crocs had a net margin of 20.50% and a return on equity of 49.70%. The company had revenue of $1.06 billion during the quarter, compared to analyst estimates of $1.05 billion. During the same period in the prior year, the business posted $3.25 EPS. The business’s revenue for the quarter was up 1.6% compared to the same quarter last year. As a group, analysts anticipate that Crocs, Inc. will post 12.93 earnings per share for the current fiscal year.

Analyst Upgrades and Downgrades

A number of equities research analysts recently weighed in on the stock. Monness Crespi & Hardt lowered their price objective on shares of Crocs from $170.00 to $140.00 and set a “buy” rating for the company in a research report on Wednesday, October 30th. Guggenheim reduced their target price on shares of Crocs from $182.00 to $155.00 and set a “buy” rating for the company in a research note on Wednesday, October 30th. Piper Sandler reissued an “overweight” rating and set a $170.00 target price on shares of Crocs in a research note on Friday, August 23rd. UBS Group reduced their target price on shares of Crocs from $146.00 to $122.00 and set a “neutral” rating for the company in a research note on Wednesday, October 30th. Finally, KeyCorp reduced their target price on shares of Crocs from $155.00 to $150.00 and set an “overweight” rating for the company in a research note on Wednesday, October 30th. Five research analysts have rated the stock with a hold rating and twelve have issued a buy rating to the stock. Based on data from MarketBeat, the company has an average rating of “Moderate Buy” and an average price target of $148.80.

Read Our Latest Stock Report on CROX

About Crocs

(Free Report)

Crocs, Inc, together with its subsidiaries, designs, develops, manufactures, markets, distributes, and sells casual lifestyle footwear and accessories for men, women, and children under Crocs and HEYDUDE Brand in the United States and internationally. The company offers various footwear products, including clogs, sandals, slides, flips, wedges, platforms, socks, boots, charms, flip flops, sneakers, and slippers.

Recommended Stories

Want to see what other hedge funds are holding CROX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Crocs, Inc. (NASDAQ:CROXFree Report).

Institutional Ownership by Quarter for Crocs (NASDAQ:CROX)

Receive News & Ratings for Crocs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Crocs and related companies with MarketBeat.com's FREE daily email newsletter.